GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ExpreS2ion Biotech Holding AB (FRA:5JD0) » Definitions » 3-Year Revenue Growth Rate

ExpreS2ion Biotech Holding AB (FRA:5JD0) 3-Year Revenue Growth Rate : -53.90% (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is ExpreS2ion Biotech Holding AB 3-Year Revenue Growth Rate?

ExpreS2ion Biotech Holding AB's Revenue per Share for the three months ended in Dec. 2024 was €0.02.

During the past 12 months, ExpreS2ion Biotech Holding AB's average Revenue per Share Growth Rate was -79.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was -53.90% per year. During the past 5 years, the average Revenue per Share Growth Rate was -36.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 12 years, the highest 3-Year average Revenue per Share Growth Rate of ExpreS2ion Biotech Holding AB was 19.60% per year. The lowest was -53.90% per year. And the median was -29.35% per year.


Competitive Comparison of ExpreS2ion Biotech Holding AB's 3-Year Revenue Growth Rate

For the Biotechnology subindustry, ExpreS2ion Biotech Holding AB's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ExpreS2ion Biotech Holding AB's 3-Year Revenue Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ExpreS2ion Biotech Holding AB's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where ExpreS2ion Biotech Holding AB's 3-Year Revenue Growth Rate falls into.


;
;

ExpreS2ion Biotech Holding AB 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


ExpreS2ion Biotech Holding AB  (FRA:5JD0) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


ExpreS2ion Biotech Holding AB 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of ExpreS2ion Biotech Holding AB's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


ExpreS2ion Biotech Holding AB Business Description

Traded in Other Exchanges
Address
c/o Mindpark, Ronnowsgatan 8c, Helsingborg, SWE, S-252 25
ExpreS2ion Biotech Holding AB has developed a technology platform, ExpreS2, for fast and efficient non-clinical development and production of complex proteins for new vaccines and diagnostics. ExpreS2 is regulatorily validated for clinical supply. The platform includes functionally modified glycosylation variants for enhanced immunogenicity and pharmacokinetics. The company has produced more than 500 proteins and virus-like particles (VLPs) in collaboration with research institutions and companies.

ExpreS2ion Biotech Holding AB Headlines

No Headlines